Stockreport

MIRA Pharmaceuticals, Inc. Announces Closing of $8.9 Million Initial Public Offering

MIRA Pharmaceuticals, Inc.  (MIRA) 
PDF BALTIMORE, Aug. 7, 2023 /PRNewswire/ -- MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical company focused on the d [Read more]